Professor Dame Sally Davies

Dame Sally is the first UK Special Envoy on Antimicrobial Resistance. Before this, she was Chief Medical Officer (CMO) for England and Chief Medical Adviser to the UK government from March 2011 to September 2019, having held the post on an interim basis since June 2010.

Dame Sally advocates globally for action and awareness on AMR. She has become a leading figure in global health, including serving as a member of the World Health Organisation (WHO) Executive Board 2014-2016. Dame Sally has spoken on AMR at numerous events including the World Health Assembly side events, the G8 science ministers’ meeting in 2015, the Global Health Security Initiative in 2015, and the UN General Assembly side events in 2016 and 2019.

She was chair of the 2013 AMR forum at the World Innovation Summit for Health (WISH) and was for three years the chair of the WHO Strategic and Technical Advisory Group on AMR. Most recently, Dame Sally was appointed as a co-convener of the UN Inter-Agency Co-ordination Group on AMR, set up in response to the AMR declaration made at UNGA 2016. She is a driving force behind the 2020 Investor Year of Action on AMR, a joint initiative between the UK Department of Health and Social Care, the Access to Medicine Foundation, the FAIRR Initiative and the UN Principles for Responsible Investment.

Dame Sally was instrumental in establishing the Fleming Fund when she was Chief Medical Officer, and now acts as an adviser to the Fleming Fund, UK Global Innovation Fund and other UK government funded AMR activities overseas. In the 2020 New Year Honours, Dame Sally became the second woman (and the first outside the Royal family) to be appointed Dame Grand Cross of the Order of the Bath (GCB) for services to public health and research, having received her DBE in 2009.

Technical Advisory Group

The Fleming Fund’s Technical Advisory Group (TAG) consists of 11 experts in AMR across the One Health sectors, who provide independent technical advice and expertise to support programmatic decisions and shape the strategic direction of the fund.

Policies & Accountability

Commitment to Safeguarding

The UK Government is at the forefront of creating an aid sector that is free from sexual exploitation, abuse and sexual harassment. We ensure that we ‘do no harm’ through UK Aid funding. Safeguarding is defined as taking all reasonable means to prevent harm, particularly sexual exploitation, abuse and harassment, from occurring, to protect people, especially vulnerable adults and children, from that harm, and to respond appropriately when harm does occur.

It’s vital to drive up standards across the aid sector, and the Fleming Fund takes all reasonable steps to: prevent sexual exploitation and abuse and sexual harassment from occurring; listen to those who are affected; respond sensitively but robustly when harm or allegations of harm occur; and, learn from every case. Evidence shows that issues of fraud and safeguarding sadly increase during pandemics. The Fleming Fund and delivery partners are particularly vigilant to potential safeguarding issues during this time.

Data Standardisation

The Fleming Fund recognises that to achieve global ambition on AMR surveillance, we must support countries to collect quality data and communicate about it in a consistent way and a common format. The Fleming Fund fully supports the development and use of globally agreed standards and methods for AMR related surveillance, while also recognising the need for adaptation to account for different resource settings and local health and economic priorities.

The Fleming Fund will continue to support the development of methods, standards and protocols for AMR surveillance that are based on globally accepted practices, and particularly those which meet the needs of LMICs. We continue to support the testing and implementation of such protocols in LMICs.

Data Sharing

The Fleming Fund supports countries to collect, share and use data. This is national data and neither DHSC, the Management Agent, nor grantees own or share the data that is gathered in the programme.

Data is collected within national health systems, by central reference laboratories and other sentinel surveillance sites, including in national hospitals, and is owned by health and food and agriculture ministries. These national government systems are responsible for reporting data internationally to global data repositories managed by the World Health Organization and the World Organisation for Animal Health. Data shared with these organisations helps decision makers worldwide to monitor global trends and emerging threats.

ODA Funding

Official development assistance (ODA) is defined by the Organisation for Economic Co-operation and Development (OECD) Development Assistance Committee (DAC) as government aid that promotes and specifically targets the economic development and welfare of developing countries.

ODA eligibility is defined by OECD as those flows to countries and territories on the DAC List of ODA recipients and to multilateral development institutions which are:

  • Provided by official agencies, including state and local governments, or by their executive agencies
  • Concessional (i.e. grants and soft loans) and administered with the promotion of the economic development and welfare of developing countries as the main objective.

The Fleming Fund is a UK aid programme and so the core objective of all our activities is to promote the economic development and welfare of the countries we work in. DHSC scrutinises all Fleming Fund investment against OECD ODA eligibility rules before any funding is committed.